Isolation and identification of cucurbitane-type triterpenoids with partial agonist/antagonist potential for estrogen receptors from Momordica charantia
- PMID: 21456596
- DOI: 10.1021/jf200418g
Isolation and identification of cucurbitane-type triterpenoids with partial agonist/antagonist potential for estrogen receptors from Momordica charantia
Abstract
This study aims at investigating the estrogenic activity and active cucurbitane-type triterpenoid compounds of bitter gourd (Momordica charantia, MC) using a transactivation assay for estrogen receptors (ER) α and β. The lyophilized fruits of MC were exhaustively extracted with ethyl acetate (EA) and 95% ethanol (EtOH), sequentially. The nonsaponifiable fraction (NS) of the EA extract as well as the acid hydrolyzed EtOH extract (AH) was fractionated and isolated by repeated column chromatography and further purified by preparative HPLC or RP-HPLC. One known compound, 5β,19-epoxycucurbita-6,24-diene-3β,23ξ-diol (6), was isolated from the NS, and five new compounds (1-5) were isolated from AH and identified as cucurbita-6,22(E),24-trien-3β-ol-19,5β-olide (1), 5β,19-epoxycucurbita-6,22(E),24-triene-3β,19-diol (2), 3β-hydroxycucurbita-5(10),6,22(E),24-tetraen-19-al (3), 19-dimethoxycucurbita-5(10),6,22(E),24-tetraen-3β-ol (4), and 19-nor-cucurbita-5(10),6,8,22(E),24-pentaen-3β-ol (5). In the noncytotoxic concentration range, compounds 1, 2, 5 and 6 showed weak agonistic activity via ER α and β. Compounds 1, 2, 3 and 6 significantly antagonized the transactvation of 17β-estradiol (E(2)) via both ER α and β. In conclusion, this study demonstrates, for the first time as far as we know, the partial agonist/antagonist activity via ER of four new and one known cucurbitane-type triterpenoids from MC. Further studies are worthy to explore the selective estrogen receptor modulator (SERM) activity of MC.
Similar articles
-
Cucurbitane-type triterpenoids from Momordica charantia.J Nat Prod. 2006 Aug;69(8):1168-71. doi: 10.1021/np068008v. J Nat Prod. 2006. PMID: 16933869
-
Cucurbitane-type triterpenoids from the stems of momordica charantia.J Nat Prod. 2008 Aug;71(8):1327-30. doi: 10.1021/np070532u. Epub 2008 Jul 19. J Nat Prod. 2008. PMID: 18637688
-
Cucurbitane-type triterpenoids from the fruit of Momordica charantia.J Nat Prod. 2005 May;68(5):807-9. doi: 10.1021/np040218p. J Nat Prod. 2005. PMID: 15921438
-
Momordica charantia Bioactive Components: Hypoglycemic and Hypolipidemic Benefits Through Gut Health Modulation.J Med Food. 2024 Jul;27(7):589-600. doi: 10.1089/jmf.2024.k.0037. Epub 2024 May 21. J Med Food. 2024. PMID: 38770678 Review.
-
New insights into the bioactive polysaccharides, proteins, and triterpenoids isolated from bitter melon (Momordica charantia) and their relevance for nutraceutical and food application: A review.Int J Biol Macromol. 2023 Mar 15;231:123173. doi: 10.1016/j.ijbiomac.2023.123173. Epub 2023 Jan 12. Int J Biol Macromol. 2023. PMID: 36642359 Review.
Cited by
-
Beneficial Impacts of Alpha-Eleostearic Acid from Wild Bitter Melon and Curcumin on Promotion of CDGSH Iron-Sulfur Domain 2: Therapeutic Roles in CNS Injuries and Diseases.Int J Mol Sci. 2021 Mar 24;22(7):3289. doi: 10.3390/ijms22073289. Int J Mol Sci. 2021. PMID: 33804820 Free PMC article. Review.
-
Effect of wild bitter gourd treatment on inflammatory responses in BALB/c mice with sepsis.Biomedicine (Taipei). 2014;4(3):17. doi: 10.7603/s40681-014-0017-y. Epub 2014 Aug 27. Biomedicine (Taipei). 2014. PMID: 25520930 Free PMC article.
-
Natural Compounds in Sex Hormone-Dependent Cancers: The Role of Triterpenes as Therapeutic Agents.Front Endocrinol (Lausanne). 2021 Jan 21;11:612396. doi: 10.3389/fendo.2020.612396. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33552000 Free PMC article. Review.
-
Activation of AMPK by bitter melon triterpenoids involves CaMKKβ.PLoS One. 2013 Apr 25;8(4):e62309. doi: 10.1371/journal.pone.0062309. Print 2013. PLoS One. 2013. PMID: 23638033 Free PMC article.
-
Unifying mechanisms of action of the anticancer activities of triterpenoids and synthetic analogs.Anticancer Agents Med Chem. 2012 Dec;12(10):1211-20. doi: 10.2174/187152012803833099. Anticancer Agents Med Chem. 2012. PMID: 22583404 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous